Hasun Matthias, Gatterer Eduard, Weidinger Franz
2. Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Juchgasse 25, 1030, Vienna, Austria.
Wien Klin Wochenschr. 2014 Nov;126(21-22):692-704. doi: 10.1007/s00508-014-0667-5. Epub 2014 Nov 20.
Atrial fibrillation (AF) is by far the most frequent heart rhythm disorder and is associated with a significantly increased risk of stroke, heart failure and death. Despite improvements in prevention and treatment, the prognosis has not changed significantly. To use new and promising pharmacological and interventional concepts for thromboembolic prophylaxis and treatment of AF, as well as prevention of recurrence, patient compliance has to be improved, physicians have to be trained and experience hast to be gained. A consistently carried 'anticoagulation pass' might be a promising piece of the puzzle.
心房颤动（AF）是目前最常见的心律失常，与中风、心力衰竭和死亡风险的显著增加相关。尽管在预防和治疗方面有所改进，但预后并未显著改变。为了将新的、有前景的药物和介入理念用于心房颤动的血栓栓塞预防和治疗以及复发预防，必须提高患者的依从性，培训医生并积累经验。持续推行的“抗凝通行证”可能是解决问题的一个有前景的部分。
